Online Hours

Hours displayed in:
Eastern Time (US & Canada)

Technology Leadership Development Program (Information Session 1)

  • 10:00 AM - 12:00 PM

Technology Leadership Development Program (Information Session 2)

  • 3:00 PM - 5:00 PM
Register to view additional information about this organization

Register

About

BD (Becton, Dickinson and Company), a leading global medical technology company, is seeking high-potential technical talent for its Technology Leadership Development Program (TLDP). The TLDP's vision is to develop future leaders of BD's R&D organization, by providing TLDP associates with broad and deep technical assignments across BD.The program consists of three successively more challenging assignments that can span multiple businesses and/or locations within the company, strengthening the technical depth and skills of these high-potential associates while developing their leadership skills and stretching them across multiple disciplines. A personalized and dynamic career path is sculpted for each individual TLDP, based on personal skills and interests, with the influence of senior R&D leaders. Assignments will focus on developing each participant's domain expertise, leadership abilities, crossfunctional skills, and business acumen.  Examples of first assignments include design and development of product components in drug delivery systems or high tech diagnostics devices, contributing to the development of a novel materials technology that enables invention of new medical devices and therapies, participating in the development of new technologies that enable better and faster disease diagnostics, or leading a novel concept. Second assignments are more complex technically and typically include providing supervision and work direction for a small team. In the third assignment leadership is further developed by increased team sizes while the technical complexity and impact of the roles are also increased.

BD is a leading global medical technology company that develops, manufactures and sells medical devices,instrument systems and reagents. The Company is dedicated to improving people's health throughout the world.BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visitwww.bd.com.